Biktarvy, formally known as bictegravir, includes a potent single-tablet treatment for managing HIV infection. This formula combines three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by preventing the HIV's ability to multiply within the body, significantly reducing the viral quantity. For many individ